Bone Mineral Density News and Research

RSS

Measuring bone marrow fat can better predict weakening of bones

BMD measurement with DEXA is presently the most commonly used parameter for determining bone weakening. Researchers have long questioned whether there may be other measurable bone components that influence mechanical stability of bone.

7 Dec 2004

Guidelines needed for the use of androgens for women with sexual dysfunction

The Endocrine Society, which represents more than 12,000 endocrinologists who are specially trained to diagnose, treat and conduct basic and clinical research on complex hormonal disorders, has called for new clinical guidelines on the use of androgens in women/female sexual dysfunction.

3 Dec 2004

Major bone trial to test high dose corticosteroid steroid tablets

Researchers in Aberdeen are about to launch a major multi-centre clinical trial to test whether a new drug could prevent bone thinning in adults taking moderate to high dose corticosteroid "steroid" tablets, such as prednisolone.

8 Nov 2004

New treatment antibody - AMG 162 - may help prevent osteoporosis and rheumatoid arthritis

A novel treatment administered semiannually to postmenopausal women with low bone density appears to rapidly inhibit the bone resorption process, resulting in improvements in bone mineral density at 12 months

18 Oct 2004

$Strontium ranelate may reduce spinal, non-spinal, hip and other fractures in older women with osteoporosis$

Strontium ranelate may reduce spinal, non-spinal, hip and other fractures in older women with osteoporosis

Strontium ranelate, a new oral medication on the horizon, may reduce spinal, non-spinal, hip and other fractures in older women with osteoporosis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in San Antonio, Texas.

18 Oct 2004

Soccer greatly improves the health profile of growing boys

Regular and long-term participation in soccer greatly improves the health profile of growing boys, according to new research published by the American College of Sports Medicine (ACSM).

12 Oct 2004

Tamoxifen increases risk of stroke in women slightly

A recent analysis of tamoxifen studies completed since 1980 revealed an increased risk of stroke in women who were randomized to tamoxifen versus placebo or other therapies. Details of the analysis and the researchers' conclusions are reported in the October 12 issue of Neurology, the scientific journal of the American Academy of Neurology.

11 Oct 2004

High calcium intake and vigorous exercise is the key to optimal increases in bone density

Prepubescence is a critical time for building bone mass in children. Strong bones are important for obvious reasons in growth and development. It is widely accepted that calcium intake and physical activity are two ways one can positively impact bone density.

27 Sep 2004

Bonviva, to treat osteoporosis, submitted for marketing authorisation in Europe

Roche and GlaxoSmithKline announced today the submission of a Marketing Authorisation Application to the European authorities for a novel, once-monthly oral formulation of their new bisphosphonate, Bonviva (ibandronate), for the treatment of postmenopausal osteoporosis.

20 Sep 2004

New early breast cancer treatment significantly reduces the risk of cancer returning

Marking the first major treatment advance since tamoxifen's introduction over 25 years ago, Canada's leading oncologists and breast cancer patient support and advocacy groups gathered to applaud a new era in treatment for early breast cancer.

15 Jul 2004

Soy protein not effective in improving memory in post menopausal women

No beneficial effects were found on cognitive function, bone mineral density or plasma lipids when postmenopausal women age 60 years or older took soy protein supplements with isoflavones for one year

7 Jul 2004

First strokes now bone health, moderate alcohol consumption good for women

Moderate drinking seems to keep brittle bones at bay in women, a new study of identical twins suggests.

1 Jul 2004

Early patient response to Forteo in postmenopausal women with osteoporosis

Changes in markers of bone remodeling after one month of treatment with FORTEO® (teriparatide [rDNA origin] injection) may provide important early evidence of treatment response, according to new data presented today at the 86th Annual Meeting of The Endocrine Society (ENDO).

17 Jun 2004

Exercise is more influential than calcium intake in determining bone strength in young women

Studies have shown that most of a female's bone mass is built between the ages of 13 and 15 and then slowly lost in the last four decades of her life. Therefore, attaining optimal bone mass and bone strength in adolescence may offer the best protection possible against osteoporosis - bone loss in post-menopausal women and the elderly.

10 Jun 2004

Intensive exercising after menopause may reduce bone loss

Early postmenopausal women with osteoporosis who participate in an intense exercise program may experience reduced bone loss, reduced back pain, and lower cholesterol levels, according to an article in the May 24 issue of The Archives of Internal Medicine, one of the JAMA/Archives journals.

24 May 2004

$Risk for future fractures in postmenopausal women$

Risk for future fractures in postmenopausal women

Two new studies in the May 24 issue of The Archives of Internal Medicine, one of the JAMA/Archives journals, examines methods to accurately classify postmenopausal women with reduced bone mass and identify those with increased risk for future fractures.

24 May 2004

Adult height loss could suggest future osteoporosis problems

The loss of 2 or more inches in height during adulthood serves as a powerful predictor of osteoporosis in the hip, and thus the risk for hip fractures, in elderly women, according to a new study at The Ohio State University Medical Center. The finding has led researchers to recommend that primary care physicians routinely screen aging patients for height loss. Seth Kantor

1 May 2004

$Untreated postmenopausal women with osteoporosis are at risk for first spinal fracture within one year$

Untreated postmenopausal women with osteoporosis are at risk for first spinal fracture within one year

Results of a new analysis found that, without treatment, one out of 13 postmenopausal osteoporotic women who were initially fracture-free were likely to experience a spinal fracture within one year.

28 Apr 2004